Filed: 11/14/2025ACC: 0001856083-25-000006
📋 What this filing means
DEEP TRACK CAPITAL, LP filed this quarterly 13F‑HR report disclosing 56 equity positions with a total reported market value of $3.58B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
56
Positions
$3.58B
Total AUM (reported)
208.30M
Total Shares
Allocation by class
COM$2.69B75.2%
COM NEW$541.78M15.1%
SPONSORED ADS$177.84M5.0%
ADS$65.39M1.8%
COM SHS$52.94M1.5%
SHS$28.20M0.8%
ORDINARY SHARES$17.88M0.5%
Portfolio Concentration
Top 3$745.00M20.8%
4–10$1.14B31.8%
11–25$1.18B32.9%
Rest$520.28M14.5%
Top 3 weight
20.8%
Top 10 weight
52.6%
Voting Authority Distribution
Total shares with voting rights: 208.30M
Sole
Full voting authority
208.30M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole56
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings56
Rows:
GUARDANT HEALTH INC
SOLEShares4.15M
TypeSH
Market value$259.55M
7.24%
Sole
4.15M
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares3.81M
TypeSH
Market value$249.13M
6.95%
Sole
3.81M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares4.30M
TypeSH
Market value$236.33M
6.60%
Sole
4.30M
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares4M
TypeSH
Market value$189.97M
5.30%
Sole
4M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares8M
TypeSH
Market value$181.05M
5.05%
Sole
8M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares3M
TypeSH
Market value$178.29M
4.98%
Sole
3M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares9.73M
TypeSH
Market value$156.83M
4.38%
Sole
9.73M
Shared
0.00
None
0.00
DYNAVAX TECHNOLOGIES CORP
SOLEShares15.73M
TypeSH
Market value$156.16M
4.36%
Sole
15.73M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares11.93M
TypeSH
Market value$139.49M
3.89%
Sole
11.93M
Shared
0.00
None
0.00
89BIO INC
SOLEShares9.36M
TypeSH
Market value$137.54M
3.84%
Sole
9.36M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares4.22M
TypeSH
Market value$118.04M
3.29%
Sole
4.22M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares5.38M
TypeSH
Market value$116.11M
3.24%
Sole
5.38M
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares1.72M
TypeSH
Market value$113.97M
3.18%
Sole
1.72M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares900K
TypeSH
Market value$109.31M
3.05%
Sole
900K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares3M
TypeSH
Market value$108.06M
3.02%
Sole
3M
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares3.95M
TypeSH
Market value$102.40M
2.86%
Sole
3.95M
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares1.80M
TypeSH
Market value$65.39M
1.82%
Sole
1.80M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares1.20M
TypeSH
Market value$62.33M
1.74%
Sole
1.20M
Shared
0.00
None
0.00
GERON CORP
SOLEShares41.10M
TypeSH
Market value$56.30M
1.57%
Sole
41.10M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares7.50M
TypeSH
Market value$56.29M
1.57%
Sole
7.50M
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares6.06M
TypeSH
Market value$55.97M
1.56%
Sole
6.06M
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares3.15M
TypeSH
Market value$55.13M
1.54%
Sole
3.15M
Shared
0.00
None
0.00
EXACT SCIENCES CORP
SOLEShares1M
TypeSH
Market value$54.71M
1.53%
Sole
1M
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares3.35M
TypeSH
Market value$52.94M
1.48%
Sole
3.35M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares2M
TypeSH
Market value$51.74M
1.44%
Sole
2M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INCSOLE | COM | 4.15M | SH | $259.55M 7.24% | 4.15M | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 3.81M | SH | $249.13M 6.95% | 3.81M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 4.30M | SH | $236.33M 6.60% | 4.30M | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 4M | SH | $189.97M 5.30% | 4M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 8M | SH | $181.05M 5.05% | 8M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 3M | SH | $178.29M 4.98% | 3M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 9.73M | SH | $156.83M 4.38% | 9.73M | 0.00 | 0.00 |
DYNAVAX TECHNOLOGIES CORPSOLE | COM NEW | 15.73M | SH | $156.16M 4.36% | 15.73M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 11.93M | SH | $139.49M 3.89% | 11.93M | 0.00 | 0.00 |
89BIO INCSOLE | COM | 9.36M | SH | $137.54M 3.84% | 9.36M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 4.22M | SH | $118.04M 3.29% | 4.22M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 5.38M | SH | $116.11M 3.24% | 5.38M | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 1.72M | SH | $113.97M 3.18% | 1.72M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 900K | SH | $109.31M 3.05% | 900K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 3M | SH | $108.06M 3.02% | 3M | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 3.95M | SH | $102.40M 2.86% | 3.95M | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 1.80M | SH | $65.39M 1.82% | 1.80M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 1.20M | SH | $62.33M 1.74% | 1.20M | 0.00 | 0.00 |
GERON CORPSOLE | COM | 41.10M | SH | $56.30M 1.57% | 41.10M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 7.50M | SH | $56.29M 1.57% | 7.50M | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 6.06M | SH | $55.97M 1.56% | 6.06M | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 3.15M | SH | $55.13M 1.54% | 3.15M | 0.00 | 0.00 |
EXACT SCIENCES CORPSOLE | COM | 1M | SH | $54.71M 1.53% | 1M | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 3.35M | SH | $52.94M 1.48% | 3.35M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 2M | SH | $51.74M 1.44% | 2M | 0.00 | 0.00 |
Page 1 of 3